Biosino Bio-Technology and Science Incorporation

HK$2.40As of Sun 8 Nov 2026, 12:00 UTC
HKEX:8247Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (0.89%)
Div yield —
ROE (43.57%)
Diagnostics & Research
Beta (5Y) 0.71
PE TTM —
TSR TTM 175.29%
Mkt cap HK$346.6M
ROIC (25.06%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.59
8.22%
(48.53%)
Hold 10|11|10|3|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.03
0.03
0.03
0.03
1.52%
(2.63%)
3.88%
11.84%
Revenue¥M
27.22
28.21
27.76
29.43
(0.96%)
5.46%
4.25%
7.26%
Peers (US$44.21M)
Cap (US$)
PE
252.1M
77.04x
Capital
TTM
5Y
10Y
Leveragex
0.378
—
—
EBIT/Intx
0.773
0.744
0.644
Own earn%
(25.90)
(125.36)
(102.81)
Sh yield%
21.09
28.99
34.87
Owners
Insiders/Inst%
3.71
20.60
Short interest%
4.02
SBC / revenue%
3.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
13–19
$1 testx
—
Incr. ROIC%
7